Effect of a Drinkable Yogurt Enriched in Proteins and Fibers on Satiety

NCT01304004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-01-23

No results posted yet for this study

Summary

Worldwide, obesity rate has increased so much in the latest years, that we call it obesity epidemic. Overweight could result of an unbalanced energetic balance for years. The person who regularly consumes more calories than she expends will find herself with a positive energetic balance, which results in a weight gain. A daily overconsumption of only 10 calories comes with a weight gain throughout one year. A way to avoid this overconsumption is to eat food that increases satiety. Satiety can be defined as the time interval after food ingestion, during which hunger and desire to eat are suppressed.

The general objective of the study is to investigate in a pilot study the impact of a drinkable yogurt enriched in proteins and fibres on satiety.

Conditions

Interventions

OTHER

Satiety

Intervention Description: Consumption of the 2 drinkable yogurts separated by 4 weeks: 1. Experimental drinkable yogurt enriched in proteins and fibres 2. Placebo drinkable yogurt (isocaloric and isovolumetric)

Sponsors & Collaborators

  • Aliments ULTIMA Foods Inc.

    collaborator INDUSTRY
  • Laval University

    lead OTHER

Principal Investigators

  • Benoît LAmarche, PhD · Institute of Nutraceutical and Functional Foods (INAF), Laval University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-12-31
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01304004 on ClinicalTrials.gov